Analysis of extemporaneous oral liquid from commercially available drugs in hospital
ABSTRACT The objective of this study was to identify drugs that received dose adjustments (DA) and pharmaceutical alternatives (PA) that avoid DA, and calculate the economic percentage of this replacement. A descriptive, observational and cross-sectional study was performed in a second level hospita...
Saved in:
Main Authors: | Jhohann Richard de Lima Benzi (Author), Patrícia De Carvalho Mastroianni (Author) |
---|---|
Format: | Book |
Published: |
Universidade de São Paulo.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Extemporaneous compounding for the drugs that may be used in COVID-19 treatment
by: Jhohann Richard de Lima Benzi
Published: (2020) -
Liquid Dosage Forms Extemporaneously Prepared from Commercially Available Products - Considering New Evidence on Stability
by: Alison Haywood, et al.
Published: (2013) -
Preparation of extemporaneous oral liquid in the hospital pharmacy
by: Márcio Robert Mattos da Silva, et al.
Published: (2020) -
Quality and stability of oral extemporaneous formulations developed from commercial tablets containing spironolactone
by: Aline Marques Rosa, et al.
Published: (2014) -
Quality and stability of oral extemporaneous formulations developed from commercial tablets containing spironolactone
by: Aline Marques Rosa, et al.
Published: (2014)